Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
98.76
+4.16 (4.40%)
At close: Nov 21, 2024, 3:54 PM
98.19
-0.57 (-0.58%)
After-hours: Nov 21, 2024, 4:00 PM EST
Axsome Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 327.34 | 386.19 | 200.84 | 86.47 | 183.88 | 219.97 | Upgrade
|
| Cash & Short-Term Investments | 327.34 | 386.19 | 200.84 | 86.47 | 183.88 | 219.97 | Upgrade
|
| Cash Growth | -21.42% | 92.29% | 132.26% | -52.97% | -16.41% | 1474.70% | Upgrade
|
| Receivables | 124.1 | 94.82 | 37.7 | - | - | - | Upgrade
|
| Inventory | 14.27 | 15.14 | 4.32 | - | - | - | Upgrade
|
| Prepaid Expenses | 13.41 | 8.12 | 2.78 | 0.05 | 0.15 | 0.41 | Upgrade
|
| Total Current Assets | 479.11 | 504.26 | 245.64 | 86.52 | 184.02 | 220.38 | Upgrade
|
| Property, Plant & Equipment | 6.41 | 7.62 | 1.14 | 0.94 | 1.79 | 0.03 | Upgrade
|
| Goodwill | 12.04 | 12.04 | 10.31 | - | - | - | Upgrade
|
| Other Intangible Assets | 48.5 | 53.29 | 59.66 | - | - | - | Upgrade
|
| Other Long-Term Assets | 15.39 | 11.03 | 14.72 | 0.32 | 0.32 | 0.14 | Upgrade
|
| Total Assets | 561.46 | 588.24 | 331.48 | 87.79 | 186.13 | 220.55 | Upgrade
|
| Accounts Payable | 64.25 | 40.68 | 38.61 | 13.15 | 13.5 | 10.94 | Upgrade
|
| Accrued Expenses | 120.9 | 90.5 | 51.63 | 9.3 | 8.71 | 10.95 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 2.6 | Upgrade
|
| Current Portion of Leases | 2.91 | 1.27 | 0.43 | 0.62 | 1.22 | - | Upgrade
|
| Other Current Liabilities | 8.13 | 6.41 | 5.9 | - | - | - | Upgrade
|
| Total Current Liabilities | 196.19 | 138.85 | 96.56 | 23.07 | 23.44 | 24.49 | Upgrade
|
| Long-Term Debt | 180 | 178.07 | 94.26 | 49.09 | 48.32 | 17.33 | Upgrade
|
| Long-Term Leases | 9.39 | 7.04 | - | - | 0.58 | - | Upgrade
|
| Other Long-Term Liabilities | 82.98 | 73.3 | 31.1 | - | - | - | Upgrade
|
| Total Liabilities | 468.56 | 397.26 | 221.92 | 72.15 | 72.34 | 41.83 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,141 | 1,027 | 705.89 | 424.83 | 392.59 | 354.61 | Upgrade
|
| Retained Earnings | -1,048 | -835.57 | -596.33 | -409.2 | -278.8 | -175.9 | Upgrade
|
| Shareholders' Equity | 92.9 | 190.98 | 109.56 | 15.63 | 113.79 | 178.72 | Upgrade
|
| Total Liabilities & Equity | 561.46 | 588.24 | 331.48 | 87.79 | 186.13 | 220.55 | Upgrade
|
| Total Debt | 192.3 | 186.37 | 94.68 | 49.71 | 50.12 | 19.93 | Upgrade
|
| Net Cash (Debt) | 135.04 | 199.82 | 106.16 | 36.76 | 133.75 | 200.03 | Upgrade
|
| Net Cash Growth | -41.54% | 88.23% | 188.77% | -72.51% | -33.13% | 2734.14% | Upgrade
|
| Net Cash Per Share | 2.84 | 4.40 | 2.61 | 0.98 | 3.59 | 5.88 | Upgrade
|
| Filing Date Shares Outstanding | 48.46 | 47.37 | 43.52 | 38.48 | 37.41 | 37.08 | Upgrade
|
| Total Common Shares Outstanding | 48.44 | 47.35 | 43.5 | 37.82 | 37.37 | 36.93 | Upgrade
|
| Working Capital | 282.93 | 365.41 | 149.08 | 63.45 | 160.59 | 195.88 | Upgrade
|
| Book Value Per Share | 1.92 | 4.03 | 2.52 | 0.41 | 3.04 | 4.84 | Upgrade
|
| Tangible Book Value | 32.36 | 125.65 | 39.59 | 15.63 | 113.79 | 178.72 | Upgrade
|
| Tangible Book Value Per Share | 0.67 | 2.65 | 0.91 | 0.41 | 3.04 | 4.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.